Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
217.00    -2.00 (-0.91%)
Bid:
217.00
Ask:
217.50
Spread: 0.50 (0.23%)
Market Cap: £599.82m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

AGM Trading Update

17 Apr 2009 07:00

RNS Number : 7204Q
Morgan Crucible Co PLC
17 April 2009
 



AGM Trading Update

At today's AGM, Tim Stevenson, OBE, Morgan Crucible's Chairman, will provide the following update.

Group revenues for the first quarter were £255m compared to £178m in the equivalent period last year with strong first year performance from NP Aerospace and the businesses acquired from Carpenter. Excluding the impact of acquisitions, first quarter revenues were up c.11% year-on-year reflecting the benefits of favourable currency translation. In Q1 we have seen, as anticipated, a continuing downward trend in end-market demand meaning that, on a constant currency basis, organic revenues were down 9% compared to Q1 2008.

Of particular note in the period since our last reported results, is the award from the Ministry of Defence of a contract for the Tactical Support Vehicle (TSV) which we announced in early April. This will generate c.£30m of new revenues for NP Aerospace in the latter part of this year and the first half of 2010. 

The refinancing of the Group's banking facilities which mature in March 2010 has progressed well and we are now in the final stages of documentation for the new facility.

Going forward, the ongoing uncertainty in the global economy clearly makes it much more difficult to forecast demand accurately. However, to ensure that we are well prepared for any further deterioration in end market conditions, we are continuing to take decisive action to reduce our operating cost base. Group overall headcount at the end of Q1, excluding acquisitions, has been reduced by over 1,000 people (c.10%) worldwide from its levels of last summer and we stand ready to take further mitigating actions as required.

Our next announcement to shareholders will be our Interim Management Statement in mid May when we will update further on the Group's trading and prospects.

Enquiries:

The Morgan Crucible Company plc  01753 837000

Mark Robertshaw, Chief Executive

Kevin Dangerfield, Chief Financial Officer 

Finsbury Group 020 7251 3801

Mike Smith

Clare Strange

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBRGDSGGBGGCL
Date   Source Headline
19th Sep 201610:52 amRNSDirector/PDMR Shareholding
13th Sep 201611:43 amRNSDirector/PDMR Shareholding
23rd Aug 20163:59 pmRNSHolding(s) in Company
28th Jul 201611:40 amRNSHolding(s) in Company
27th Jul 20167:00 amRNSHalf-Year Results
29th Jun 20161:19 pmRNSHolding(s) in Company
29th Jun 20161:16 pmRNSHolding(s) in Company - Amendment
22nd Jun 201611:59 amRNSHolding(s) in Company
20th Jun 201611:22 amRNS2015 Environmental, Health and Safety Report
15th Jun 201610:18 amRNSBlock listing Interim Review
31st May 20162:55 pmRNSDirector/PDMR Shareholding
24th May 201612:31 pmRNSDirector/PDMR Shareholding
6th May 20162:23 pmRNSResult of AGM
6th May 20167:00 amRNSTrading update
18th Apr 20162:39 pmRNSDirector/PDMR Shareholding
8th Apr 20167:00 amRNSAppointment of Non-Executive Director
7th Apr 20164:30 pmRNSDirector/PDMR Shareholding
6th Apr 20161:18 pmRNSAnnual Financial Report
5th Apr 20167:00 amRNSDirectorate Change
30th Mar 20167:00 amRNSAppointment of Chief Financial Officer
24th Mar 20167:00 amRNSBoard Change
24th Feb 20161:08 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSFinal Results
4th Feb 201610:56 amRNSDirectorate Change
1st Feb 20161:56 pmRNSDirector Declaration
22nd Jan 20167:00 amRNSAppointment of a Non-Executive Director
14th Jan 201612:33 pmRNSHolding(s) in Company
30th Dec 201510:10 amRNSDirector/PDMR Shareholding
18th Dec 20152:22 pmRNSDirector/PDMR Shareholding
16th Dec 20151:26 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
15th Dec 20153:56 pmRNSHolding(s) in Company
15th Dec 20153:16 pmRNSBlocklisting Interim Review
2nd Dec 20159:10 amRNSHolding(s) in Company
26th Nov 201512:22 pmRNSDirector/PDMR Shareholding
24th Nov 20153:25 pmRNSHolding(s) in Company
13th Nov 201512:18 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSTrading Update
9th Oct 201511:14 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSBoard Change
29th Sep 20152:47 pmRNSDirector/PDMR Shareholding
25th Sep 201510:43 amRNSDirector Declaration
17th Sep 201511:50 amRNSHolding(s) in Company
11th Sep 201511:23 amRNSHolding(s) in Company
10th Sep 20153:21 pmRNSHolding(s) in Company
2nd Sep 20159:11 amRNSDirector/PDMR Shareholding
20th Aug 201512:07 pmRNSDirector/PDMR Shareholding
4th Aug 201510:13 amRNSDirector/PDMR Shareholding
22nd Jul 20157:00 amRNSHalf Yearly Results
2nd Jul 20155:22 pmRNSHolding(s) in Company
15th Jun 20153:53 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.